CytomX Therapeutics, Inc. (CTMX)
NASDAQ·Healthcare·Biotechnology
$3.01
+0.67%
Mkt Cap $482.47M
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (21 analysts)
$11.50
Range $10.00 – $16.00
Implied Upside
+282.7%
Consensus $11.50 vs current $3.01
NASDAQ·Healthcare·Biotechnology
$3.01
+0.67%
Mkt Cap $482.47M
Buy
13
Hold
0
Sell
0
Price Target (21 analysts)
$11.50
Range $10.00 – $16.00
+282.7%
Consensus $11.50 vs current $3.01